Reck M - Search Results

1

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.

Carbone DP, Reck M, Paz-Ares L, Creelan B, Horn L, Steins M, Felip E, van den Heuvel MM, Ciuleanu TE, Badin F, Ready N, Hiltermann TJN, Nair S, Juergens R, Peters S, Minenza E, Wrangle JM, Rodriguez-Abreu D, Borghaei H, Blumenschein GR Jr, Villaruz LC, Havel L, Krejci J, Corral Jaime J, Chang H, Geese WJ, Bhagavatheeswaran P, Chen AC, Socinski MA; CheckMate 026 Investigators. Carbone DP, et al. Among authors: reck m. N Engl J Med. 2017 Jun 22;376(25):2415-2426. doi: 10.1056/NEJMoa1613493. N Engl J Med. 2017. PMID: 28636851 Free PMC article.

2

Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer.

Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L. Gatzemeier U, et al. Among authors: reck m. J Clin Oncol. 1992 May;10(5):818-23. doi: 10.1200/JCO.1992.10.5.818. J Clin Oncol. 1992. PMID: 1314891 Clinical Trial.

3

Carboplatin/etoposide/vincristine therapy in small cell lung cancer.

Gatzemeier U, von Pawel J, Laumen R, Hossfeld DK, Neuhauss R, Reck M, Lenaz L. Gatzemeier U, et al. Among authors: reck m. Oncology. 1992;49 Suppl 1:25-33. doi: 10.1159/000227107. Oncology. 1992. PMID: 1323809 Clinical Trial.

4

Phase II and III studies with carboplatin in small cell lung cancer.

Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L. Gatzemeier U, et al. Among authors: reck m. Semin Oncol. 1992 Feb;19(1 Suppl 2):28-36. Semin Oncol. 1992. PMID: 1329220 Clinical Trial.

5

Carboplatin in small cell lung cancer.

Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L. Gatzemeier U, et al. Among authors: reck m. Semin Oncol. 1991 Feb;18(1 Suppl 2):8-16. Semin Oncol. 1991. PMID: 1846981 Clinical Trial.

6

Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.

Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U. Reck M, et al. J Natl Cancer Inst. 2003 Aug 6;95(15):1118-27. doi: 10.1093/jnci/djg017. J Natl Cancer Inst. 2003. PMID: 12902441 Clinical Trial.

7

Chemotherapy in stage-IV NSCLC.

Reck M, Gatzemeier U. Reck M, et al. Lung Cancer. 2004 Aug;45 Suppl 2:S217-22. doi: 10.1016/j.lungcan.2004.07.972. Lung Cancer. 2004. PMID: 15552802 Review.

8

[Phase II-trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small-cell-lung-cancer (NSCLC)].

Reck M, von Pawel J, Nimmermann C, Groth G, Gatzemeier U. Reck M, et al. Pneumologie. 2004 Dec;58(12):845-9. doi: 10.1055/s-2004-830056. Pneumologie. 2004. PMID: 15597251 Clinical Trial. German.

9

Gefitinib ("Iressa"): a new therapy for advanced non-small-cell lung cancer.

Reck M, Gatzemeier U. Reck M, et al. Respir Med. 2005 Mar;99(3):298-307. doi: 10.1016/j.rmed.2004.08.009. Respir Med. 2005. PMID: 15733505 Free article. Review.

10

Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.

Reck M, Groth G, Buchholz E, Goetz E, Gatzemeier U, Manegold C. Reck M, et al. Lung Cancer. 2005 Jun;48(3):409-13. doi: 10.1016/j.lungcan.2004.11.013. Epub 2005 Jan 23. Lung Cancer. 2005. PMID: 15893010 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

520 results

Search Page